Company Comparison
Veracyte vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Veracyte | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | South San Francisco, CA | — |
| Founded | 2008 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $142M | — |
| Valuation | — | — |
What They Build
Veracyte
Genomic diagnostics company that develops molecular tests to help physicians make treatment decisions for patients with thyroid, lung, and breast diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Veracyte
Shared Investors
5 firms have invested in both Veracyte and 10x Genomics.
Sector Overlap
Both Veracyte and 10x Genomics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.